Maria Chiara Sighinolfi, Ahmed Eissa, Luigi Bevilacqua, Ahmed Zoeir, Silvia Ciarlariello, Elena Morini, Stefano Puliatti, Viviana Durante, Pier Luca Ceccarelli, Salvatore Micali, Giampaolo Bianchi, Bernardo Rocco
- PMID: 31541411
- DOI: 10.1007/s40272-019-00355-5
Abstract
Drug-induced nephrolithiasis is a rare condition in children. The involved drugs may be divided into two different categories according to the mechanism involved in calculi formation. The first one includes poorly soluble drugs that favor the crystallization and calculi formation. The second category includes drugs that enhance calculi formation through their metabolic effects. The diagnosis of these specific calculi depends on a detailed medical history, associated comorbidities and the patient’s history of drug consumption. There are several risk factors associated with drug-induced stones, such as high dose of consumed drugs and long duration of treatment. Moreover, there are some specific risk factors, including urinary pH and the amount of fluid consumed by children. There are limited data regarding pediatric lithogenic drugs, and hence, our aim was to perform a comprehensive review of the literature to summarize these drugs and identify the possible mechanisms involved in calculi formation and discuss the management and preventive measures for these calculi.
